- Home
- BAH vs NBIX Comparison
BAH vs NBIX Comparison
Compare BAH & NBIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BAH
- NBIX
- Stock Information
- Founded
- BAH 1914
- NBIX 1992
- Country
- BAH United States
- NBIX United States
- Employees
- BAH N/A
- NBIX N/A
- Industry
- BAH Professional Services
- NBIX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- BAH Consumer Discretionary
- NBIX Health Care
- Exchange
- BAH Nasdaq
- NBIX Nasdaq
- Market Cap
- BAH 13.9B
- NBIX 13.2B
- IPO Year
- BAH 2010
- NBIX 1996
- Fundamental
- Price
- BAH $111.51
- NBIX $128.39
- Analyst Decision
- BAH Hold
- NBIX Strong Buy
- Analyst Count
- BAH 11
- NBIX 22
- Target Price
- BAH $131.40
- NBIX $165.59
- AVG Volume (30 Days)
- BAH 2.0M
- NBIX 1.0M
- Earning Date
- BAH 07-25-2025
- NBIX 07-30-2025
- Dividend Yield
- BAH 1.97%
- NBIX N/A
- EPS Growth
- BAH 75.51
- NBIX 2.97
- EPS
- BAH 8.15
- NBIX 3.39
- Revenue
- BAH $11,962,000,000.00
- NBIX $2,509,900,000.00
- Revenue This Year
- BAH $2.54
- NBIX $16.12
- Revenue Next Year
- BAH $5.33
- NBIX $15.06
- P/E Ratio
- BAH $13.68
- NBIX $37.86
- Revenue Growth
- BAH 9.25
- NBIX 18.42
- 52 Week Low
- BAH $98.95
- NBIX $84.23
- 52 Week High
- BAH $190.59
- NBIX $154.87
- Technical
- Relative Strength Index (RSI)
- BAH 56.12
- NBIX 45.54
- Support Level
- BAH $106.47
- NBIX $124.54
- Resistance Level
- BAH $109.33
- NBIX $137.44
- Average True Range (ATR)
- BAH 3.81
- NBIX 3.40
- MACD
- BAH 0.04
- NBIX -0.94
- Stochastic Oscillator
- BAH 43.59
- NBIX 29.84
About BAH Booz Allen Hamilton Holding Corporation
Booz Allen Hamilton Holding Corp is a provider of management consulting services to the U.S. government. Other services offered include technology, such as cloud computing and cybersecurity consulting, and engineering consulting. The consulting services are focused on defense, intelligence, and civil markets. In addition to the U.S. government, Booz Allen Hamilton provides its management and technology consulting services to large corporations, institutions, and nonprofit organizations. The company assists clients in long-term engagements around the globe.
About NBIX Neurocrine Biosciences Inc.
Neurocrine Biosciences Inc engages in the discovery, development, and commercialization of drugs for the treatment of neurological and endocrine-related diseases and disorders in the United States. The company's products include INGREZZA for tardive dyskinesia and chorea associated with Huntington's disease; ALKINDI for adrenal insufficiency; Efmody capsules for classic congenital adrenal hyperplasia; Orilissa tablets for endometriosis; and Oriahnn capsules to treat uterine fibroids.